Pillar · Biotech Investing
Biotech Due Diligence Checklist: How to Evaluate a Drug Pipeline and Probability of Approval
Most biotech investors skip due diligence and pay the price. This step-by-step checklist walks you through everything yo...
Start here
Pillar · Clinical Readouts
How to Read Biotech Clinical Trial Data: Phase 1, 2, 3 Results Explained for Investors
Clinical trial data is the single most important factor in biotech investing, but most investors struggle to read it. Th...
FDA & PDUFA Calendar
FDA Drug Approval Process
The FDA drug approval process ensures that new medications are safe, effective, and meet rigorous scientific standards before reaching the market. This multi-ph...
Catalyst Analysis
Our Top 10 BioPharma Stocks from Q2 BioHedge Funds Data!
Return from August 15, 2024: +11.41% 🚀 Return for the Last 1 Month: +12.63%✅ Return for the Last 1 Year: +111.97%💯 Hey everyone, we've analyzed data from ...
FDA & PDUFA Calendar
August 2024 PDUFAs Drug Approval Outlook
Let's dive into the most anticipated PDUFA dates and see what our crystal ball (and some solid data) tells us about their approval chances. Plus, we'll see how ...
FDA & PDUFA Calendar
Top 10 Potential Biotech buyout in 2024
The biotech and pharmaceutical industries are constantly evolving, with mergers and acquisitions (M&A) serving as key catalysts for change, innovation, and grow...
FDA & PDUFA Calendar
Biotech Stock Catalysts and PDUFA Dates: The Pharma Watch List for Investors
A biotech catalyst watch list is a dated list of events that can revalue a company in one session. This guide covers which catalyst types are worth tracking, ho...
FDA & PDUFA Calendar
List of 10 Potential Deals in Q1 2024 for Small and Mid-Cap Biotech and Pharma Companies
Argenx, a Belgian biotechnology company (ARGX), is reportedly interested in acquiring Akari Therapeutics, a British biotechnology company (AKTX), in a deal that...
FDA & PDUFA Calendar
Vertex and CRISPR Therapeutics: Transformative Milestone with CASGEVY™ Authorization for Sickle Cell Disease and Beta Thalassemia
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) marked a significant milestone as the United Kingdom (U.K.) Medicines ...
FDA & PDUFA Calendar
Top 10 Biotech Companies Pioneering the Future of Healthcare
The biotechnology industry is a dynamic and rapidly evolving field, offering a diverse range of investment opportunities for individuals with varying risk appet...
FDA & PDUFA Calendar
BiopharmaWatch FDA Calendar Guide: Track Every Biotech Catalyst and PDUFA Date in Real Time
A PDUFA date is the deadline the FDA sets itself to decide on a drug application, and it is the most tradeable date in biotech. This guide explains what the dat...